Publication | Closed Access
No correlation between BRAF<sup>V600E</sup> mutation and clinicopathological features of papillary thyroid carcinomas in Taiwan
124
Citations
38
References
2005
Year
BRAFV600E mutation is the most prevalent oncogene in PTCs in Taiwan. Our data did not suggest that BRAFV600E mutation could be a potentially useful marker of prognosis in patients with papillary carcinomas in the population studied.
| Year | Citations | |
|---|---|---|
Page 1
Page 1